-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, I9O+mqa8sykE/e4jZSv6JZvcRnNw2BJ2hhjotsletOM0qF6yc8IBBrR5aXYFqgw1 /xeIGF/077X0gE/mNe3kjQ== 0000898432-08-000842.txt : 20080819 0000898432-08-000842.hdr.sgml : 20080819 20080818194042 ACCESSION NUMBER: 0000898432-08-000842 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20080819 DATE AS OF CHANGE: 20080818 GROUP MEMBERS: ANDREEFF EQUITY ADVISORS, L.L.C. GROUP MEMBERS: MAPLE LEAF CAPITAL I, L.L.C. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ENDOCARE INC CENTRAL INDEX KEY: 0001003464 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 330618093 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-50293 FILM NUMBER: 081026178 BUSINESS ADDRESS: STREET 1: 201 TECHNOLOGY DRIVE CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 8004184677 MAIL ADDRESS: STREET 1: 201 TECHNOLOGY DRIVE CITY: IRVINE STATE: CA ZIP: 92618 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ANDREEFF DANE CENTRAL INDEX KEY: 0001201810 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: C/O ANDREEFF EQUITY ADVISORS LLC STREET 2: 450 LAUREL STREET STE 2105 CITY: BATON ROUGE STATE: LA ZIP: 70801 BUSINESS PHONE: 2253447780 MAIL ADDRESS: STREET 1: C/O ANDREEFF EQUITY ADVISORS LLC STREET 2: 450 LAUREL ST STE 2105 CITY: BATON ROUGE STATE: LA ZIP: 70801 SC 13G/A 1 endocare-13ga.txt - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (RULE 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(b) (Amendment No. 1) Endocare, Inc. ------------------------------------------------------------------------ (Name of Issuer) Common Stock ------------------------------------------------------------------------ (Title of Class of Securities) 29264P203 ------------------------------------------------------------------------ (CUSIP Number) June 12, 2008 ------------------------------------------------------------------------ (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [X] Rule 13d-1(c) [ ] Rule 13d-1(d) - -------------------------------------------------------------------------------- *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, SEE the NOTES). - -------------------------------------------------------------------------------- - --------------------- --------------------- CUSIP No. 29264P203 13G PAGE 2 of 7 PAGES - --------------------- --------------------- - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON: Andreeff Equity Advisors, L.L.C. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / / (b) /X/ - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER 0 NUMBER OF ---------------------------------------------------------------- SHARES BENEFICIALLY 6 SHARED VOTING POWER OWNED 1,351,511 ---------------------------------------------------------------- BY 7 SOLE DISPOSITIVE POWER EACH 0 REPORTING ---------------------------------------------------------------- PERSON WITH: 8 SHARED DISPOSITIVE POWER 1,351,511 - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,351,511 - -------------------------------------------------------------------------------- 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / / - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 11.5% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* IA, PN - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- - --------------------- --------------------- CUSIP No. 29264P203 13G PAGE 3 of 7 PAGES - --------------------- --------------------- - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON: Dane Andreeff - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / / (b) /X/ - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Canada - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER 0 NUMBER OF ---------------------------------------------------------------- SHARES BENEFICIALLY 6 SHARED VOTING POWER OWNED 1,351,511 ---------------------------------------------------------------- BY 7 SOLE DISPOSITIVE POWER EACH 0 REPORTING ---------------------------------------------------------------- PERSON WITH: 8 SHARED DISPOSITIVE POWER 1,351,511 - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,351,511 - -------------------------------------------------------------------------------- 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / / - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 11.5% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* IN, HC - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- - --------------------- --------------------- CUSIP No. 29264P203 13G PAGE 4 of 7 PAGES - --------------------- --------------------- - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON: Maple Leaf Capital I, L.L.C. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / / (b) /X/ - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER 0 NUMBER OF ---------------------------------------------------------------- SHARES BENEFICIALLY 6 SHARED VOTING POWER OWNED 843,039 ---------------------------------------------------------------- BY 7 SOLE DISPOSITIVE POWER EACH 0 REPORTING ---------------------------------------------------------------- PERSON WITH: 8 SHARED DISPOSITIVE POWER 843,039 - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 843,039 - -------------------------------------------------------------------------------- 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / / - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 7.1% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* PN, HC - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- - --------------------- --------------------- CUSIP No. 29264P203 13G PAGE 5 of 7 PAGES - --------------------- --------------------- - -------------------------------------------------------------------------------- ITEM 1(a). NAME OF ISSUER: Endocare, Inc. ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: 201 Technology Drive Irvine, CA 92618 ITEM 2(a). NAME OF PERSON FILING: This Schedule 13G is being filed on behalf of the following persons (the "Reporting Persons"): (i) Andreeff Equity Advisors, L.L.C. ("AEA") (ii) Dane Andreeff (iii) Maple Leaf Capital I, L.L.C. ("Capital") ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE: The principal business office of the Reporting Persons filing this Schedule 13G is located at 140 East St. Lucia Lane, Santa Rosa Beach, FL 32459. ITEM 2(c). CITIZENSHIP: (i) AEA: a Delaware limited liability company (ii) Dane Andreeff: Canada (iii) Capital: a Delaware limited liability company ITEM 2(d). TITLE OF CLASS OF SECURITIES: Common Stock ITEM 2(e). CUSIP Number: 29264P203 - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- - --------------------- --------------------- CUSIP No. 29264P203 13G PAGE 6 of 7 PAGES - --------------------- --------------------- ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULE 13d-1(b), or 13d-2(b) OR (c)CHECK WHETHER THE PERSON FILING IS: ONE OF THE FOLLOWING Not applicable. ITEM 4. OWNERSHIP: The information in items 1 and 5 through 11 on the cover pages (pp. 2 - -4) on this Schedule 13G is hereby incorporated by reference. ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS: If this statement is being filed to report the fact that as of the date hereof the Reporting Persons have ceased to be the beneficial owner of more than five percent of the class of securities check the following. / / ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON: Not applicable. ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY: Mr. Andreeff is the Managing Member of AEA and Capital. AEA is the Investment Adviser and Capital is the General Partner of the following limited partnerships, each of which owns less than 5% of the issuer's securities: (i) Maple Leaf Partners, L.P. (ii) Maple Leaf Partners I, L.P. (iii) Maple Leaf Discovery, L.P. (iv) Maple Leaf Discovery I, L.P. AEA is the Investment Adviser of Maple Leaf Discovery Offshore, Ltd. and Maple Leaf Offshore, Ltd., each of which owns less than 5% of the issuer's securities. Mr. Andreeff is the Director of Maple Leaf Discovery Offshore, Ltd. and Maple Leaf Offshore, Ltd. ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF A GROUP: Not applicable. ITEM 9. NOTICE OF DISSOLUTION OF GROUP: Not applicable. - -------------------------------------------------------------------------------- - --------------------- --------------------- CUSIP No. 29264P203 13G PAGE 7 of 7 PAGES - --------------------- --------------------- ITEM 10. CERTIFICATION By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: August 18, 2008 /s/ Dane Andreeff __________________________________ Dane Andreeff * ANDREEFF EQUITY ADVISORS, L.L.C.* By: /s/ Dane Andreeff ______________________________ Name: Dane Andreeff Title: Managing Member MAPLE LEAF CAPITAL I, L.L.C.* By: /s/ Dane Andreeff ______________________________ Name: Dane Andreeff Title: Managing Member * THE REPORTING PERSONS DISCLAIM BENEFICIAL OWNERSHIP IN THE SHARES REPORTED HEREIN EXCEPT TO THE EXTENT OF THEIR PECUNIARY INTEREST THEREIN. EX-99 2 endocare-exhibit99.txt EXHIBIT A In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, each of the undersigned does hereby consent and agree to the joint filing on behalf of each of them of a statement on Schedule 13G and all amendments thereto with respect to the Common Stock of Endocare, Inc. beneficially owned by each of them, and the inclusion of this Joint Filing Agreement as an exhibit thereto. Dated: August 18, 2008 /s/ Dane Andreeff _________________________________ Dane Andreeff ANDREEFF EQUITY ADVISORS, L.L.C. By: /s/ Dane Andreeff _____________________________ Name: Dane Andreeff Title: Managing Member MAPLE LEAF CAPITAL I, L.L.C. By: /s/ Dane Andreeff ______________________________ Name: Dane Andreeff Title: Managing Member -----END PRIVACY-ENHANCED MESSAGE-----